Catalyst Funds Management Pty »

Oramed Pharm shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Oramed Pharm (ORMP) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Oramed Pharm

Tip: Access up to 7 years of quarterly data

All positions including Oramed Pharm held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oramed Pharm by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2026-03-31 $80k 24k 3.40

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
Rio Tinto Adr (RIO)
Arm Holdings Adr (ARM)
Astrazeneca Ordinary Shares (AZN)
Medline Ordinary Shares (MDLN)
Cisco Systems Ordinary Shares (CSCO)
Abbvie Ordinary Shares (ABBV)
Teradyne Ordinary Shares (TER)
TechnipFMC Ordinary Shares (FTI)
Elbit Systems Ordinary Shares (ESLT)
Exxon Mobil Corp. Ordinary Shares (XOM)
Walmart Ordinary Shares (WMT)
Cheniere Energy Ordinary Shares (LNG)
Revolution Medicines Ordinary Shares (RVMD)
Valero Energy Corp. Ordinary Shares (VLO)

View all positions for Catalyst Funds Management Pty

Top funds holding Oramed Pharm

BML Capital Management
Aquamarine Financial
Mercer Global Advisors
SB Capital Management
Murchinson
Boothbay Fund Management
Marshall Wace
Rathbones Brothers
Dimensional Fund Advisors
Wells Fargo & Company
Comprehensive Portfolio Management
Renaissance Technologies
Bank of America Corporation
O'shaughnessy Asset Management
Citadel Advisors

View all funds holding Oramed Pharm